Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 Patients.
Journal: Clinical lung cancer
Published: April 05, 2026
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.
Journal: Clinical lung cancer
Published: March 26, 2026
Socioeconomic Impact of Artemether-Lumefantrine in Malaria Treatment across Sub-Saharan Africa: A Model-Based Historical Analysis with 2022 as Reference Year.
Journal: The American journal of tropical medicine and hygiene
Published: September 05, 2025
First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 13, 2025
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
Journal: British journal of cancer
Published: November 10, 2023
Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study.
Journal: Clinical lung cancer
Published: April 07, 2023
Real-world data for precision cancer medicine-A European perspective.
Journal: Genes, chromosomes & cancer
Published: January 13, 2023
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach.
Journal: Translational lung cancer research
Published: March 14, 2022
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 19, 2022
Current Management and Future Perspective in Pleural Mesothelioma.
Journal: Cancers
Published: January 12, 2022
Last Updated: 09/26/2026